Daily non-political popular news in brief.

Blood-vessel blocker aids cancer-killing virus

11-27-2007 · EurekAlert!

Cancer-killing viruses are a promising therapy for incurable brain tumors, but their effectiveness has been limited in part because immune cells rapidly eliminate them. That immune response might be slowed, and the virus given more time to kill cancer cells, by blocking the growth of blood vessels in the tumor, new Ohio State research suggests. The study indicates that pretreatment with a drug that blocks blood-vessel growth might improve the effectiveness of cancer-killing viruses.

Keywords: blood-vessel, blocker, aids, cancer-killing, virus, blood, vessel, aid, cancer, killing, viru

« Previous | Next »

Similar news on "Blood-vessel blocker aids cancer-killing virus":

JCI table of contents: Oct. 25, 2007
10-25-2007 · EurekAlert!
This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, Oct. 25, 2007, in the JCI, including: Drug that lowers blood pressure might help prevent Alzheimer disease; How to design a cancer killing virus; Being big hearted isn't always good news; Histamine receptor makes T cells attack; Early bird: TGF-beta acts early in a multiple sclerosis-like disease in mice; and others.
Similar news · Read more »
Discovery of an HIV inhibitor in human blood points to new drug class
04-19-2007 · EurekAlert!
A new study has pinpointed a natural ingredient of human blood that effectively blocks HIV-1, the virus predominantly responsible for human AIDS, from infecting immune cells and multiplying. The virus blocker might play a role in the progression of HIV to full-blown AIDS and -- because it works in a different way than existing antiretroviral inhibitors -- could lead to the development of another class of drugs in the fight against the pandemic disease.
Similar news · Read more »
HIV isolate from Kenya provides clues for vaccine design
01-02-2008 · EurekAlert!
Two simple changes in its outer envelope protein could render the AIDS virus vulnerable to attack by the immune system, according to research from Kenya and the Fred Hutchinson Cancer Research Center published in PLoS Medicine.
Similar news · Read more »
Jefferson researchers boost immune 'killer cells,' increase antibody effectiveness against cancer
04-18-2007 · EurekAlert!
Researchers have devised a novel method to expand the number of immune system "natural killer (NK)" cells from blood cells outside the body. They have shown in laboratory studies that adding such cells to anti-cancer therapies involving monoclonal antibody drugs such as Herceptin, which targets the HER2/neu protein on breast cancer cells, is more effective in killing cancer cells, and perhaps someday may improve treatments.
Similar news · Read more »
Researchers find that childhood sarcoma increases risk of blood clots
04-18-2007 · EurekAlert!
Researchers at NCI have determined that children and young adults with a form of cancer called sarcoma are at increased risk of having a thromboembolic event in their veins. Thromboembolic events can be a blood clot in a vessel that can interfere with normal blood flow. Investigating the association between sarcoma and TE is important because the majority of children with sarcoma can be cured of their cancer, but the occurrence of TEs could adversely compromise this success.
Similar news · Read more »
JCI table of contents: Aug. 16, 2007
08-16-2007 · EurekAlert!
This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, Aug. 16, 2007, in the JCI, including: "Can cancer drugs combine forces?"; "Specific antagonism lowers blood pressure"; "Eyeing up a role for S1P2R in abnormal blood vessel formation"; "A winning combination for the treatment of cancer"; "How tumors prevent immune cell entry"; and "1, 2, 3: third gene responsible for genetic disorder identified."
Similar news · Read more »
An AIDS-related virus reveals more ways to cause cancer, Penn researchers find
10-08-2007 · EurekAlert!
Researchers have shed new light on how Kaposi's Sarcoma-associated Herpes Virus subverts normal cell machinery to cause cancer. A KSHV protein called latency-associated nuclear antigen (LANA) helps the virus hide out from the immune system in infected cells. When LANA takes the place of other proteins that control cell growth, it can cause uncontrolled cell replication.
Similar news · Read more »
Dengue and other hemorrhagic fevers: Towards a first potential treatment
12-22-2006 · EurekAlert!
IRD immuno-virologists and their research partners have determined the mechanisms involved in the occurrence of the vascular leakage triggered by the Dengue virus. Metalloproteinases are responsible for the passage of plasma across the blood-vessel walls. These original results, validated first by in vitro tests then in vivo on a mouse model, open up the first line of attack for treatment against hemorrhagic Dengue and new perspectives for others hemorrhagic fevers, such as Ebola.
Similar news · Read more »
How to design a cancer-killing virus
10-25-2007 · EurekAlert!
One new way to treat individuals with cancer that is being developed is the use of viruses that infect and kill cancer cells while leaving normal cells unharmed. These viruses are known as virotherapeutics. In a new study in the Journal of Clinical Investigation the development of a new virotherapuetic that had antitumor effects in both mice and rabbits is described.
Similar news · Read more »
Genetic marker linked to aggressive prostate cancer
05-20-2007 · EurekAlert!
Northwestern University researchers have discovered that a recently identified genetic marker for prostate cancer is linked to a highly aggressive form of the disease. These findings ultimately will aid the development of a simple blood test to predict who is susceptible to this aggressive cancer. Knowing which patients carry this genetic marker also will guide doctors in how they treat the cancer. The study showed a strong hereditary component to this aggressive cancer.
Similar news · Read more »